{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:26:43Z","timestamp":1786771603549,"version":"build-2736575974"},"reference-count":102,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010446","name":"Batten Disease Family Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005468","name":"Batten Disease Support and Research Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005468","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001543","name":"Neurological Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.bbadis.2015.04.026","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T12:43:58Z","timestamp":1430916238000},"page":"2292-2300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"PB","title":["Experimental therapies in the neuronal ceroid lipofuscinoses"],"prefix":"10.1016","volume":"1852","author":[{"given":"Nicole J.","family":"Neverman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbadis.2015.04.026_bb0005","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1089\/hum.2005.16.741","article-title":"Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses","volume":"16","author":"Abordo-Adesida","year":"2005","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s002340050427","article-title":"MRI of neuronal ceroid lipofuscinosis. II. Postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type","volume":"39","author":"Autti","year":"1997","journal-title":"Neuroradiology"},{"issue":"3","key":"10.1016\/j.bbadis.2015.04.026_bb0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymgme.2006.02.016","article-title":"A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis","volume":"89","author":"Awano","year":"2006","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.bbadis.2015.04.026_bb0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ymgme.2005.11.005","article-title":"A mutation in the cathepsin D gene (CTSD) in American bulldogs with neuronal ceroid lipofuscinosis","volume":"87","author":"Awano","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2015.04.026_bb0025","series-title":"BioMarin Provides Preliminary Data from Ongoing Phase 1\/2 Pivotal Study of BMN190 for Treatment of CLN2 Disorder, a Form of Batten Disease","author":"BioMarin","year":"2014"},{"issue":"3","key":"10.1016\/j.bbadis.2015.04.026_bb0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/bjh.13059","article-title":"Transplantation in inborn errors of metabolism: current considerations and future perspectives","volume":"167","author":"Boelens","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/clim.1999.4724","article-title":"Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration","volume":"92","author":"Brockstedt","year":"1999","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.bbadis.2015.04.026_bb0040","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/jmg.35.9.717","article-title":"Ovine neuronal ceroid lipofuscinosis: a large animal model syntenic with the human neuronal ceroid lipofuscinosis variant CLN6","volume":"35","author":"Broom","year":"1998","journal-title":"J. Med. Genet."},{"issue":"4","key":"10.1016\/j.bbadis.2015.04.026_bb0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.bbadis.2015.04.026_bb0050","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/hmg\/11.12.1421","article-title":"An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease","volume":"11","author":"Chattopadhyay","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.bbadis.2015.04.026_bb0055","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.2025","article-title":"Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy","volume":"15","author":"Chen","year":"2009","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bbadis.2015.04.026_bb0060","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","article-title":"Immune responses to adenovirus and adeno-associated virus in humans","volume":"6","author":"Chirmule","year":"1999","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0065","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/JVI.74.5.2420-2425.2000","article-title":"Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle","volume":"74","author":"Chirmule","year":"2000","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0070","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1751-0813.2002.tb10847.x","article-title":"Neuronal ceroid lipofuscinosis in Merino sheep","volume":"80","author":"Cook","year":"2002","journal-title":"Aust. Vet. J."},{"issue":"10","key":"10.1016\/j.bbadis.2015.04.026_bb0075","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbadis.2006.08.002","article-title":"Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis","volume":"1762","author":"Cooper","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.bbadis.2015.04.026_bb0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1566523054546224","article-title":"Altering the tropism of lentiviral vectors through pseudotyping","volume":"5","author":"Cronin","year":"2005","journal-title":"Curr. Genet. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbrc.2010.03.137","article-title":"Palmitoyl:protein thioesterase (PPT1) inhibitors can act as pharmacological chaperones in infantile Batten disease","volume":"395","author":"Dawson","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/BC.2008.009","article-title":"A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity","volume":"389","author":"Fan","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.04.026_bb0095","series-title":"Guidance for Industry M3(R2)","author":"FDA","year":"2010"},{"key":"10.1016\/j.bbadis.2015.04.026_bb0100","first-page":"69","article-title":"Recent trends in the gene therapy of beta-thalassemia","volume":"6","author":"Finotti","year":"2015","journal-title":"J. Blood Med."},{"key":"10.1016\/j.bbadis.2015.04.026_bb0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2014.09.018","article-title":"Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption","volume":"196","author":"Foley","year":"2014","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.bbadis.2015.04.026_bb0110","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2004.03.005","article-title":"Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Griffey","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.bbadis.2015.04.026_bb0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ymthe.2005.04.018","article-title":"AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis","volume":"12","author":"Griffey","year":"2005","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.bbadis.2015.04.026_bb0120","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ymthe.2005.11.008","article-title":"CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis","volume":"13","author":"Griffey","year":"2006","journal-title":"Mol. Ther."},{"issue":"5644","key":"10.1016\/j.bbadis.2015.04.026_bb0125","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.bbadis.2015.04.026_bb0130","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bbadis.2006.06.010","article-title":"The neuronal ceroid-lipofuscinoses: from past to present","volume":"1762","author":"Haltia","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.bbadis.2015.04.026_bb0135","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbadis.2012.08.012","article-title":"The neuronal ceroid-lipofuscinoses: a historical introduction","volume":"1832","author":"Haltia","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.bbadis.2015.04.026_bb0140","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/BF00686210","article-title":"Neurovisceral ceroid-lipofuscinosis in blind Devon cattle","volume":"75","author":"Harper","year":"1988","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/sj.gt.3301843","article-title":"Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system","volume":"10","author":"Haskell","year":"2003","journal-title":"Gene Ther."},{"issue":"10","key":"10.1016\/j.bbadis.2015.04.026_bb0150","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.1128\/JVI.73.10.8549-8558.1999","article-title":"Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model","volume":"73","author":"Hernandez","year":"1999","journal-title":"J. Virol."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2015.04.026_bb0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymgme.2012.05.009","article-title":"Intravenous high-dose enzyme replacement therapy with recombinant palmitoyl-protein thioesterase reduces visceral lysosomal storage and modestly prolongs survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis","volume":"107","author":"Hu","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.bbadis.2015.04.026_bb0160","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ajmg.1320420436","article-title":"Sheep and other animals with ceroid-lipofuscinoses: their relevance to Batten disease","volume":"42","author":"Jolly","year":"1992","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1751-0813.1997.tb13839.x","article-title":"Ceroid-lipofuscinosis in miniature Schnauzer dogs","volume":"75","author":"Jolly","year":"1997","journal-title":"Aust. Vet. J."},{"issue":"6","key":"10.1016\/j.bbadis.2015.04.026_bb0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/00480169.1976.34298","article-title":"Blindness in South Hampshire sheep: a neuronal ceroid lipofuscinosis","volume":"24","author":"Jolly","year":"1976","journal-title":"N. Z. Vet. J."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2015.04.026_bb0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.bbadis.2015.04.026_bb0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/hum.2009.179","article-title":"A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein","volume":"22","author":"Kato","year":"2011","journal-title":"Hum. Gene Ther."},{"issue":"11","key":"10.1016\/j.bbadis.2015.04.026_bb0185","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/jnr.23423","article-title":"Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)","volume":"92","author":"Katz","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2015.04.026_bb0190","first-page":"198042","article-title":"A missense mutation in canine CLN6 in an Australian shepherd with neuronal ceroid lipofuscinosis","volume":"2011","author":"Katz","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bbadis.2015.04.026_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1742-2094-10-97","article-title":"Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progression","volume":"10","author":"Kay","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbadis.2015.04.026_bb0200","doi-asserted-by":"crossref","DOI":"10.1007\/s13365-014-0308-9","article-title":"Genome editing strategies: potential tools for eradicating HIV-1\/AIDS","author":"Khalili","year":"2015","journal-title":"J. Neurovirol."},{"issue":"8","key":"10.1016\/j.bbadis.2015.04.026_bb0205","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.54.8.1589","article-title":"AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys","volume":"54","author":"Konitsiotis","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2015.04.026_bb0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajmg.1320310616","article-title":"The English setter with ceroid-lipofuscinosis: a suitable model for the juvenile type of ceroid-lipofuscinosis in humans","volume":"5","author":"Koppang","year":"1988","journal-title":"Am. J. Med. Genet. Suppl."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/humu.21624","article-title":"Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses","volume":"33","author":"Kousi","year":"2012","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0220","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.expneurol.2007.09.012","article-title":"Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease","volume":"209","author":"Kovacs","year":"2008","journal-title":"Exp. Neurol."},{"issue":"2\u20133","key":"10.1016\/j.bbadis.2015.04.026_bb0225","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuropharm.2010.10.010","article-title":"Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease","volume":"60","author":"Kovacs","year":"2011","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bbadis.2015.04.026_bb0230","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0022-510X(78)90087-4","article-title":"Early-juvenile Batten's disease\u2014a recognisable sub-group distinct from other forms of Batten's disease. Analysis of 5 patients","volume":"36","author":"Lake","year":"1978","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-973677","article-title":"Bone marrow transplantation in late infantile Batten disease and juvenile Batten disease","volume":"28","author":"Lake","year":"1997","journal-title":"Neuropediatrics"},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0240","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00219337","article-title":"Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease","volume":"88","author":"Leinekugel","year":"1992","journal-title":"Hum. Genet."},{"issue":"8","key":"10.1016\/j.bbadis.2015.04.026_bb0245","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1474-4422(14)70142-5","article-title":"Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study","volume":"13","author":"Levin","year":"2014","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0250","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2990.2006.00738.x","article-title":"Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis","volume":"32","author":"Lim","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"Pt 1","key":"10.1016\/j.bbadis.2015.04.026_bb0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/bj3570049","article-title":"Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis","volume":"357","author":"Lin","year":"2001","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.bbadis.2015.04.026_bb0265","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1089\/hum.2011.026","article-title":"Lentiviral-mediated gene transfer to the sheep brain: implications for gene therapy in Batten disease","volume":"22","author":"Linterman","year":"2011","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.bbadis.2015.04.026_bb0270","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2133.2004.05813.x","article-title":"Misdiagnosis of Fabry disease: importance of biochemical confirmation of clinical or pathological suspicion","volume":"150","author":"Linthorst","year":"2004","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.bbadis.2015.04.026_bb0275","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/WNL.57.8.1411","article-title":"Hematopoietic stem cell transplantation in infantile neuronal ceroid lipofuscinosis","volume":"57","author":"Lonnqvist","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.bbadis.2015.04.026_bb0280","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ymgme.2009.12.002","article-title":"Human recombinant palmitoyl-protein thioesterase-1 (PPT1) for preclinical evaluation of enzyme replacement therapy for infantile neuronal ceroid lipofuscinosis","volume":"99","author":"Lu","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0285","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/cr.2013.157","article-title":"Generating rats with conditional alleles using CRISPR\/Cas9","volume":"24","author":"Ma","year":"2014","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.bbadis.2015.04.026_bb0290","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.23545","article-title":"Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis","volume":"71","author":"Macauley","year":"2012","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.bbadis.2015.04.026_bb0295","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00405140","article-title":"Bovine ceroid-lipofuscinosis (Batten's disease): the major component stored is the DCCD-reactive proteolipid, subunit C, of mitochondrial ATP synthase","volume":"15","author":"Martinus","year":"1991","journal-title":"Vet. Res. Commun."},{"issue":"85","key":"10.1016\/j.bbadis.2015.04.026_bb0300","first-page":"379","article-title":"Humoral immunity to AAV vectors in gene therapy: challenges and potential solutions","volume":"15","author":"Masat","year":"2013","journal-title":"Disc. Med."},{"issue":"16","key":"10.1016\/j.bbadis.2015.04.026_bb0305","doi-asserted-by":"crossref","first-page":"8446","DOI":"10.1128\/JVI.76.16.8446-8454.2002","article-title":"Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain","volume":"76","author":"Mastakov","year":"2002","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0310","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0315","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbadis.2015.04.026_bb0320","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ymthe.2006.01.008","article-title":"Transient gene expression by nonintegrating lentiviral vectors","volume":"13","author":"Nightingale","year":"2006","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0325","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2005.01.025","article-title":"Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6)","volume":"20","author":"Oswald","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2007-973666","article-title":"Different patterns of hydrophobic protein storage in different forms of neuronal ceroid lipofuscinosis (NCL, Batten disease)","volume":"28","author":"Palmer","year":"1997","journal-title":"Neuropediatrics"},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0335","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","article-title":"Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis","volume":"26","author":"Passini","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2015.04.026_bb0340","series-title":"14th International Conference on Neuronal Ceroid Lipofuscinoses (Batten Disease), Cordoba, Argentina","article-title":"New animal models for the study of Batten disease","author":"Pearce","year":"2014"},{"issue":"52","key":"10.1016\/j.bbadis.2015.04.026_bb0345","doi-asserted-by":"crossref","first-page":"42508","DOI":"10.1074\/jbc.M507380200","article-title":"High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease","volume":"280","author":"Pears","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"47","key":"10.1016\/j.bbadis.2015.04.026_bb0350","doi-asserted-by":"crossref","first-page":"17684","DOI":"10.1073\/pnas.0606197103","article-title":"Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo","volume":"103","author":"Philippe","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bbadis.2015.04.026_bb0355","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1042\/BST0381489","article-title":"In utero gene transfer to the mouse nervous system","volume":"38","author":"Rahim","year":"2010","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"10.1016\/j.bbadis.2015.04.026_bb0360","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/gt.2008.186","article-title":"Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors","volume":"16","author":"Rahim","year":"2009","journal-title":"Gene Ther."},{"issue":"Suppl. 5","key":"10.1016\/j.bbadis.2015.04.026_bb0365","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1528-1167.2009.02117.x","article-title":"The autosomal recessively inherited progressive myoclonus epilepsies and their genes","volume":"50","author":"Ramachandran","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbadis.2015.04.026_bb0370","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.1320310606","article-title":"Batten disease: past, present, and future","volume":"5","author":"Rider","year":"1988","journal-title":"Am. J. Med. Genet. Suppl."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0375","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10545-011-9446-x","article-title":"Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis","volume":"35","author":"Roberts","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0380","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ymthe.2006.01.006","article-title":"Gene therapy for lysosomal storage diseases","volume":"13","author":"Sands","year":"2006","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.bbadis.2015.04.026_bb0385","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0520","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/gt.2015.3","article-title":"Chimeric rabies SADB19-VSVg-pseudotyped lentiviral vectors mediate long-range retrograde transduction from the mouse spinal cord","volume":"22","author":"Schoderboeck","year":"2015","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0395","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1023\/B:BOLI.0000042959.44318.7c","article-title":"Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease","volume":"27","author":"Schueler","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0400","first-page":"1","article-title":"NCL disorders: frequent causes of childhood dementia","volume":"7","author":"Schulz","year":"2013","journal-title":"Iran. J. Child Neurol."},{"issue":"11","key":"10.1016\/j.bbadis.2015.04.026_bb0405","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/stem.718","article-title":"In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases","volume":"29","author":"Sebastiano","year":"2011","journal-title":"Stem Cells"},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2015.04.026_bb0410","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.024","article-title":"Immunosuppression alters disease severity in juvenile Batten disease mice","volume":"230","author":"Seehafer","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.bbadis.2015.04.026_bb0415","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3171\/2013.3.PEDS12397","article-title":"Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis","volume":"11","author":"Selden","year":"2013","journal-title":"J. Neurosurg. Pediatr."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0420","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2353\/ajpath.2010.091267","article-title":"CNS-expressed cathepsin D prevents lymphopenia in a murine model of congenital neuronal ceroid lipofuscinosis","volume":"177","author":"Shevtsova","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bbadis.2015.04.026_bb0425","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ymgme.2008.01.014","article-title":"Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis","volume":"94","author":"Sleat","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"41","key":"10.1016\/j.bbadis.2015.04.026_bb0430","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","article-title":"A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration","volume":"24","author":"Sleat","year":"2004","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbadis.2015.04.026_bb0435","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.mt.6300049","article-title":"Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector","volume":"15","author":"Sondhi","year":"2007","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0440","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1089\/hgtb.2012.120","article-title":"Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis","volume":"23","author":"Sondhi","year":"2012","journal-title":"Hum. Genet. Ther. Methods"},{"issue":"2","key":"10.1016\/j.bbadis.2015.04.026_bb0445","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3171\/2010.4.PEDS09507","article-title":"Gene therapy for late infantile neuronal ceroid lipofuscinosis: neurosurgical considerations","volume":"6","author":"Souweidane","year":"2010","journal-title":"J. Neurosurg. Pediatr."},{"issue":"6","key":"10.1016\/j.bbadis.2015.04.026_bb0450","doi-asserted-by":"crossref","first-page":"e38310","DOI":"10.1371\/journal.pone.0038310","article-title":"Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system","volume":"7","author":"Staropoli","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0455","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/522236","article-title":"Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance","volume":"81","author":"Sun","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.bbadis.2015.04.026_bb0460","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.stem.2009.05.022","article-title":"Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"5","author":"Tamaki","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.bbadis.2015.04.026_bb0465","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ajmg.1320420438","article-title":"Ceroid lipofuscinosis in the border collie dog: retinal lesions in an animal model of juvenile Batten disease","volume":"42","author":"Taylor","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2015.04.026_bb0470","series-title":"14th International Conference on Neuronal Ceroid Lipofuscinoses (Batten Disease). Cordoba, Argentina, Medicina","article-title":"Gene therapy for late infantile neuronal ceroid lipofuscinosis in large animal models","author":"Tecedor LK","year":"2014"},{"issue":"Suppl. A","key":"10.1016\/j.bbadis.2015.04.026_bb0475","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/ejpn.2000.0433","article-title":"Congenital ovine neuronal ceroid lipofuscinosis\u2014a cathepsin D deficiency with increased levels of the inactive enzyme","volume":"5","author":"Tyynela","year":"2001","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"4","key":"10.1016\/j.bbadis.2015.04.026_bb0480","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s004010000298","article-title":"Equine neuronal ceroid lipofuscinosis","volume":"101","author":"Url","year":"2001","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.bbadis.2015.04.026_bb0485","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2011.0370","article-title":"Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders","volume":"9","author":"Valenzano","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.bbadis.2015.04.026_bb0490","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.exer.2014.06.008","article-title":"Enzyme replacement therapy delays pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"125","author":"Whiting","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0495","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.026_bb0500","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.bbadis.2015.04.026_bb0505","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nbt.2884","article-title":"Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype","volume":"32","author":"Yin","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.026_bb0510","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12977-015-0150-z","article-title":"The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA","volume":"12","author":"Zhu","year":"2015","journal-title":"Retrovirology"},{"issue":"6","key":"10.1016\/j.bbadis.2015.04.026_bb9000","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1042\/BST0381484","article-title":"Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosis","volume":"38","author":"Wong","year":"2010","journal-title":"Biochem. Soc. Trans."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915001325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915001325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:36:53Z","timestamp":1786768613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443915001325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":102,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0925443915001325"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.04.026","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental therapies in the neuronal ceroid lipofuscinoses","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}